Cite
HARVARD Citation
Rohde, U. et al. (2017). The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes. Diabetes, obesity & metabolism. 19 (2), pp. 189-199. [Online].